VITRO DIAGNOSTICS INC | Business Contracts

Form of Convertible Note and Warrant Purchase Agreement (Filed With SEC on January 30, 2023)

Memorandum of Understanding, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 30, 2023)

Standstill Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 30, 2023)

Addendum to Employment Agreement (Separation Agreement), dated February 19, 2021, by and between the Registrant and Keith Burge (Filed With SEC on September 9, 2022)

Lease Agreement, dated July 1, 2020, by and between Kokopelli Properties, LLC and the Registrant (Filed With SEC on September 9, 2022)

Agreement and Plan of Merger, dated August 1, 2021, by and among Fitore, Inc., the Registrant, Vitro Acquisition Corp. No. 1 and the Fitore Stockholders named therein (Filed With SEC on September 9, 2022)

Form of 8% Convertible Promissory Note (Filed With SEC on January 30, 2023)

Supply Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 30, 2023)

Mutual Release and Settlement Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (Filed With SEC on January 30, 2023)

Description of Capital Stock (Filed With SEC on January 30, 2023)

Form of Warrant to Purchase Stock (Filed With SEC on January 30, 2023)

Joint Operating Agreement, dated July 14, 2020, by and between The Partners Stem Cell Centre (PSCC) Ltd. and the Registrant (Filed With SEC on September 9, 2022)

Executive Employment Agreement, dated November 30, 2020, by and between the Registrant and John Evans (Filed With SEC on September 9, 2022)

Subscription Agreement and 4% Unsecured Promissory Note Due December 31, 2025, dated November 1, 2020, by and between the Registrant and James Musick (Filed With SEC on September 9, 2022)

Subscription Agreement and 6% Unsecured Promissory Note Due December 31, 2025, dated November 1, 2020, by and between the Registrant and James Musick (Filed With SEC on September 9, 2022)

Convertible Promissory Note, dated May 31, 2022, issued by the Registrant to Bruce Peterson (Filed With SEC on September 9, 2022)

Joint Operating Agreement, dated August 6, 2021, by and among European Wellness Biomedical Group, Bio Peptides LLC and the Registrant (Filed With SEC on September 9, 2022)

Amendment, dated April 28, 2022, to Joint Operating Agreement, dated August 6, 2021, by and among European Wellness Biomedical Group, Bio Peptides LLC and the Registrant (Filed With SEC on September 9, 2022)

Joint Development Agreement, dated May 15, 2018, by and between the Registrant and Jack Zamora (Filed With SEC on September 9, 2022)

Note Purchase Agreement, dated May 31, 2022, by and between the Registrant and Bruce Peterson (Filed With SEC on September 9, 2022)

Consultant Agreement, dated October 1, 2021, by and between the Registrant and Innovative Strategies & Solutions, Inc (Filed With SEC on September 9, 2022)

Note Purchase Agreement, dated May 31, 2022, by and between the Registrant and Kevin Melling (Filed With SEC on September 9, 2022)

Convertible Promissory Note, dated May 31, 2022, issued by the Registrant to Kevin Melling (Filed With SEC on September 9, 2022)

Executive Employment Agreement, dated December 2, 2020, by and between the Registrant and Keith Burge (Filed With SEC on September 9, 2022)

Executive Employment Agreement, dated October 1, 2021, by and between Nathan Haas and the Registrant (Filed With SEC on September 9, 2022)

Agreement and Plan of Exchange, dated August 1, 2021, by and among Infinivive MD, LLC, Jack Zamora, its Sole Member, and the Registrant (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated May 1, 2018, by and between the Registrant and John R. Evans (Filed With SEC on September 9, 2022)

Form of Common Stock Certificate (Filed With SEC on September 9, 2022)

Form of Stock Purchase Warrant A (Filed With SEC on September 9, 2022)

Form of Stock Purchase Warrant B (Filed With SEC on September 9, 2022)

2022 Equity Incentive Plan (Filed With SEC on September 9, 2022)

Amendment to the 2022 Equity Incentive Plan (Filed With SEC on September 9, 2022)

Form of Incentive Stock Option Grant Notice and Stock Option Agreement under the 2022 Incentive Award Plan (Filed With SEC on September 9, 2022)

Form of Non-Statutory Stock Option Grant Notice and Stock Option Agreement under the 2022 Incentive Award Plan (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated May 1, 2018, by and between the Registrant and James Musick (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated November 30, 2020, by and between the Registrant and John R. Evans (Filed With SEC on September 9, 2022)

Executive Employment Agreement, dated December 1, 2020, between the Registrant and Jack Zamora (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated November 30, 2020, by and between the Registrant and James R. Musick (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated December 1, 2020, by and between the Registrant and Jack Zamora (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated April 9, 2020, by and between the Registrant and Jack Zamora (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated August 1, 2021, by and between the Registrant and Nathan Haas (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated October 1, 2021, by and between the Registrant and Caroline Mosessian (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated October 1, 2021, by and between the Registrant and John R. Evans (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated October 1, 2021, by and between the Registrant and Nathan Haas (Filed With SEC on September 9, 2022)

Non-Statutory Stock Option Agreement, dated February 1, 2021, by and between the Registrant and Caroline Mosessian (Filed With SEC on September 9, 2022)

Executive Employment Agreement, dated December 1, 2020, between the Registrant and James R. Musick (Filed With SEC on September 9, 2022)

Memorandum of Understanding (Filed With SEC on June 4, 2020)

VITRO DIAGNOSTICS INC (47)